{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:59:47Z","timestamp":1793296787503,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81891012"],"award-info":[{"award-number":["81891012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2022C001"],"award-info":[{"award-number":["2022C001"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115541","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T16:53:53Z","timestamp":1695228833000},"page":"115541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate"],"prefix":"10.1016","volume":"167","author":[{"given":"Minghao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangkai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-6147","authenticated-orcid":false,"given":"Hui","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"02","key":"10.1016\/j.biopha.2023.115541_bib1","first-page":"57","article-title":"Research status of vegetable matter toosendanin","author":"Zhao","year":"1987","journal-title":"J. South China Agric. Univ."},{"key":"10.1016\/j.biopha.2023.115541_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.795565","article-title":"Limonoids from the genus melia (Meliaceae): phytochemistry, synthesis, bioactivities, pharmacokinetics, and toxicology","volume":"12","author":"Fan","year":"2022","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/rcm.2878","article-title":"Qualitative and quantitative analysis of toosendanin in Melia toosendan Sieb. Et Zucc (Meliaceae) with liquid chromatography\/tandem mass spectrometry","volume":"21","author":"Ong","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.biopha.2023.115541_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1365\/s10337-009-1170-4","article-title":"Determination of toosendanin extracted from traditional chinese medicine: the fruit of melia azedarach LC\u2013FD detection","volume":"70","author":"Meng","year":"2009","journal-title":"Chroma"},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib5","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.bmc.2009.12.030","article-title":"Toosendanin: synthesis of the AB-ring and investigations of its anti-botulinum properties (Part II)","volume":"18","author":"Nakai","year":"2010","journal-title":"Bioorg. Med Chem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib6","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bmc.2008.12.042","article-title":"Function-oriented synthesis applied to the anti-botulism natural product toosendanin.","volume":"17","author":"Nakai","year":"2009","journal-title":"Bioorg. Med Chem."},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/ppl.13189","article-title":"Characterization of a 2,3-oxidosqualene cyclase in the toosendanin biosynthetic pathway of Melia toosendan","volume":"170","author":"Lian","year":"2020","journal-title":"Physiol. Plant"},{"issue":"6","key":"10.1016\/j.biopha.2023.115541_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10637-005-0909-5","article-title":"Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine","volume":"23","author":"Zhang","year":"2005","journal-title":"Invest N. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib9","article-title":"Mechanisms involved in the anti-tumor effects of Toosendanin in glioma cells","volume":"21","author":"Zhang","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib10","first-page":"135","article-title":"Toosendanin induces the apoptosis of human Ewing's sarcoma cells via the mitochondrial apoptotic pathway","volume":"20","author":"Gao","year":"2019","journal-title":"Mol. Med Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/cbdd.13762","article-title":"Identification of potential modulators of osteosarcoma metastasis by high-throughput cellular screening of natural products","volume":"97","author":"Long","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tiv.2012.09.013","article-title":"Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells","volume":"27","author":"Ju","year":"2013","journal-title":"Toxicol. Vitr."},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib13","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3892\/ijo.2017.4139","article-title":"Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC-7901 cells partly via miR-200a-mediated downregulation of \u03b2-catenin pathway","volume":"51","author":"Wang","year":"2017","journal-title":"Int J. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3892\/ijo.2015.3157","article-title":"Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"47","author":"Wang","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2023.115541_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109739","article-title":"Toosendanin and isotoosendanin suppress triple-negative breast cancer growth via inducing necrosis, apoptosis and autophagy","volume":"351","author":"Zhang","year":"2022","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2023.115541_bib16","doi-asserted-by":"crossref","first-page":"42748","DOI":"10.1038\/srep42748","article-title":"Reversal of the apoptotic resistance of non-small-cell lung carcinoma towards TRAIL by natural product toosendanin","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2023.115541_bib17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1142\/S0192415X2150083X","article-title":"Toosendanin shows potent efficacy against human ovarian cancer through caspase-dependent mitochondrial apoptotic pathway","volume":"49","author":"Wang","year":"2021","journal-title":"Am. J. Chin. Med"},{"issue":"13","key":"10.1016\/j.biopha.2023.115541_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1055\/s-0029-1240902","article-title":"Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis","volume":"76","author":"He","year":"2010","journal-title":"Planta Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-023-02666-5","article-title":"Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth","volume":"42","author":"Jia","year":"2023","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2023.115541_bib20","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.2147\/CMAR.S240268","article-title":"Toosendanin suppresses glioma progression property and induces apoptosis by regulating miR-608\/Notch Axis","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res."},{"issue":"47","key":"10.1016\/j.biopha.2023.115541_bib21","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1038\/onc.2017.270","article-title":"Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2023.115541_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2021.05.010","article-title":"WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2\/Stat3 and Wnt\/\u03b2-catenin signaling","volume":"513","author":"Yang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2023.115541_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114014","article-title":"Toosendanin-induced apoptosis in colorectal cancer cells is associated with the \u03ba-opioid receptor\/\u03b2-catenin signaling axis","volume":"177","author":"Wang","year":"2020","journal-title":"Biochem Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/ddr.21951","article-title":"Toosendanin inhibits colorectal cancer cell growth through the Hedgehog pathway by targeting Shh","volume":"83","author":"Zhang","year":"2022","journal-title":"Drug Dev. Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbrc.2017.08.170","article-title":"A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt\/mTOR signaling","volume":"493","author":"Pei","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"issue":"9","key":"10.1016\/j.biopha.2023.115541_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrm.2016.108","article-title":"Cell signalling: signalling to cell cycle arrest","volume":"17","author":"Strzyz","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2018.09.093","article-title":"Toosendanin induces caspase-dependent apoptosis through the p38 MAPK pathway in human gastric cancer cells","volume":"505","author":"Zhou","year":"2018","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2023.115541_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2004.03.023","article-title":"Involvement of cytochrome c release and caspase activation in toosendanin-induced PC12 cell apoptosis","volume":"201","author":"Tang","year":"2004","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","article-title":"The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update","volume":"89","author":"Siddiqui","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib30","first-page":"262","article-title":"Toosendanin induces apoptosis of human gastric cancer MGC-803 cells and its mechanism","volume":"37","author":"Xu","year":"2021","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/vco.12889","article-title":"Toosendanin-induced apoptosis of CMT-U27 is mediated through the mitochondrial apoptotic pathway","volume":"21","author":"Yang","year":"2023","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.biopha.2023.115541_bib32","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2013.16","article-title":"Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers","volume":"16","author":"Wu","year":"2014","journal-title":"Expert Rev. Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI84424","article-title":"Targeting noncoding RNAs in disease","volume":"127","author":"Adams","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib34","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1159\/000366353","article-title":"MiR-23a functions as a tumor suppressor in osteosarcoma","volume":"34","author":"He","year":"2014","journal-title":"Cell Physiol. Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12935-016-0342-1","article-title":"MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3","volume":"16","author":"Liu","year":"2016","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib36","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3892\/mmr.2020.11263","article-title":"Toosendanin induces apoptosis of MKN-45 human gastric cancer cells partly through miR-23a-3p-mediated downregulation of BCL2","volume":"22","author":"Shao","year":"2020","journal-title":"Mol. Med Rep."},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2005.01.021","article-title":"Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis","volume":"231","author":"Lazennec","year":"2006","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","article-title":"Estrogen receptor alpha and beta in health and disease","volume":"29","author":"Jia","year":"2015","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10549-009-0413-2","article-title":"Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells","volume":"120","author":"Treeck","year":"2010","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib40","first-page":"110","article-title":"Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner","volume":"49","author":"Hsu","year":"2006","journal-title":"Chin. J. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115541_bib41","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/ijms17111928","article-title":"Toosendanin exerts an anti-cancer effect in glioblastoma by inducing estrogen receptor \u03b2- and p53-mediated apoptosis","volume":"17","author":"Cao","year":"2016","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.abb.2005.01.009","article-title":"Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity","volume":"436","author":"Keszler","year":"2005","journal-title":"Arch. Biochem Biophys."},{"issue":"8\u20139","key":"10.1016\/j.biopha.2023.115541_bib43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1081\/NCN-200027586","article-title":"Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis","volume":"23","author":"Keszler","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"12","key":"10.1016\/j.biopha.2023.115541_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052536","article-title":"The apoptotic effects of toosendanin are partially mediated by activation of deoxycytidine kinase in HL-60 cells","volume":"7","author":"Ju","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005867","article-title":"The interplay between Myc and CTP synthase in drosophila","volume":"12","author":"Aughey","year":"2016","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.biopha.2023.115541_bib46","first-page":"633","article-title":"Effects of Toosendanin on the formation of CTPS cytoophidium in human gastric cancer cell MKN-45 and its mechanism","volume":"36","author":"Chen","year":"2020","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.biopha.2023.115541_bib47","first-page":"1126","article-title":"Interference of CTPS gene promotes toosendanin-induced apoptosis of human gastric cancer MKN-45 cells","volume":"42","author":"Luo","year":"2022","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3892\/ijo.2014.2318","article-title":"The translation elongation factor eEF2 is a novel tumor-associated antigen overexpressed in various types of cancers","volume":"44","author":"Oji","year":"2014","journal-title":"Int J. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115541_bib49","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","article-title":"The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation","volume":"1813","author":"Plotnikov","year":"2011","journal-title":"Biochim Biophys. Acta"},{"issue":"12","key":"10.1016\/j.biopha.2023.115541_bib50","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/emboj.2012.150","article-title":"The many faces and functions of \u03b2-catenin","volume":"31","author":"Valenta","year":"2012","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib51","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/med.21787","article-title":"Direct targeting of \u03b2-catenin in the Wnt signaling pathway: current progress and perspectives","volume":"41","author":"Wang","year":"2021","journal-title":"Med Res Rev."},{"key":"10.1016\/j.biopha.2023.115541_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnmol.2011.00047","article-title":"Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors","volume":"4","author":"Mills","year":"2011","journal-title":"Front Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115541_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2005.07.075","article-title":"Evaluation of potential STAT3-regulated genes in human breast cancer","volume":"335","author":"Hsieh","year":"2005","journal-title":"Biochem Biophys. Res Commun."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.17305\/bjbms.2018.2756","article-title":"The role of the Hedgehog signaling pathway in cancer: a comprehensive review","volume":"18","author":"Skoda","year":"2018","journal-title":"Bosn. J. Basic Med Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib56","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1089\/ars.2011.4394","article-title":"p62 at the interface of autophagy, oxidative stress signaling, and cancer","volume":"17","author":"Nezis","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2023.115541_bib57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ncb2976","article-title":"Oncogenic roles of EMT-inducing transcription factors","volume":"16","author":"Puisieux","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115541_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5070063","article-title":"Mechanisms of TGF\u03b2-induced epithelial-mesenchymal transition","volume":"5","author":"Moustakas","year":"2016","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.biopha.2023.115541_bib59","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/ptr.6132","article-title":"Toosendanin, a natural product, inhibited TGF-\u03b21-induced epithelial-mesenchymal transition through ERK\/Snail pathway","volume":"32","author":"Luo","year":"2018","journal-title":"Phytother. Res"},{"key":"10.1016\/j.biopha.2023.115541_bib60","doi-asserted-by":"crossref","first-page":"9423907","DOI":"10.1155\/2019\/9423907","article-title":"The role of matrix metalloproteinases in the epithelial-mesenchymal transition of hepatocellular carcinoma","volume":"2019","author":"Scheau","year":"2019","journal-title":"Anal. Cell Pathol"},{"issue":"7","key":"10.1016\/j.biopha.2023.115541_bib61","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/cam4.1591","article-title":"Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection","volume":"7","author":"Zhou","year":"2018","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib62","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3892\/or.2016.4680","article-title":"ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells","volume":"35","author":"Shi","year":"2016","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10555-018-9728-y","article-title":"Developing TRAIL\/TRAIL death receptor-based cancer therapies","volume":"37","author":"Yuan","year":"2018","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib64","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s11418-018-1211-0","article-title":"Toosendanin mediates cisplatin sensitization through targeting Annexin A4\/ATP7A in non-small cell lung cancer cells","volume":"72","author":"Zheng","year":"2018","journal-title":"J. Nat. Med"},{"key":"10.1016\/j.biopha.2023.115541_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154571","article-title":"Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195\/ERK\/\u03b2-catenin pathway.","volume":"109","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.115541_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2018.03.022","article-title":"Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor","volume":"152","author":"Kai","year":"2018","journal-title":"Biochem Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2023.115541_bib67","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1002\/ptr.7174","article-title":"Synergistic effect of toosendanin and regorafenib against cell proliferation and migration by regulating WWOX signaling pathway in hepatocellular carcinoma","volume":"35","author":"Yang","year":"2021","journal-title":"Phytother. Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.115541_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115541_bib69","doi-asserted-by":"crossref","DOI":"10.1007\/s42977-023-00165-4","article-title":"Delineating the twin role of autophagy in lung cancer","author":"Zhang","year":"2023","journal-title":"Biol. Futur"},{"issue":"7","key":"10.1016\/j.biopha.2023.115541_bib70","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.7150\/ijbs.71041","article-title":"Toosendanin, a novel potent vacuolar-type H+-translocating ATPase inhibitor, sensitizes cancer cells to chemotherapy by blocking protective autophagy","volume":"18","author":"Dong","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13020-022-00605-8","article-title":"Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy","volume":"17","author":"Zhang","year":"2022","journal-title":"Chin. Med"},{"issue":"683","key":"10.1016\/j.biopha.2023.115541_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1126\/scitranslmed.abq3558","article-title":"Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy","volume":"15","author":"Yang","year":"2023","journal-title":"Sci. Transl. Med"},{"issue":"8","key":"10.1016\/j.biopha.2023.115541_bib73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.biopha.2023.115541_bib74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-biophys-111821-104732","article-title":"Molecular mechanisms underlying neurotransmitter release","volume":"51","author":"Rizo","year":"2022","journal-title":"Annu Rev. Biophys."},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib75","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharm. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2023.115541_bib77","unstructured":"Zou Jing, Ye Hongjin, He Xiangyi, Yu Yixin, Xia Hongqi, Zhang Linsen, Zhang Aiping, Zhu Shaowen Effect of Toosendanin tablets on botulism patients [J]."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib78","first-page":"29","article-title":"The effect of toosendanin on monkey botulism","volume":"5","author":"Zou","year":"1985","journal-title":"J. Tradit. Chin. Med"},{"issue":"06","key":"10.1016\/j.biopha.2023.115541_bib79","article-title":"Effect of toosendanin on botulism in animals","volume":"13","author":"Li","year":"1982","journal-title":"Chin. J. Tradit. Chin. Med."},{"key":"10.1016\/j.biopha.2023.115541_bib80","first-page":"480","article-title":"Antagonistic effect of toosendanin to botulinum toxin on neuromuscular preparations of mice","volume":"4","author":"Li","year":"1983","journal-title":"Acta Physiol. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib81","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-282X2005000100035","article-title":"Botulinum toxin: mechanisms of action","volume":"63","author":"Dressler","year":"2005","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1745-7254.2006.00236.x","article-title":"Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane.","volume":"27","author":"Li","year":"2006","journal-title":"Acta Pharm. Sin."},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.chom.2011.06.012","article-title":"Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly","volume":"10","author":"Sun","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib84","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1073\/pnas.0812839106","article-title":"Bimodal modulation of the botulinum neurotoxin protein-conducting channel","volume":"106","author":"Fischer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.115541_bib85","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxicon.2013.05.011","article-title":"A closer look to botulinum neurotoxin type A-induced analgesia","volume":"71","author":"Guo","year":"2013","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib86","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0014-5793(03)01291-2","article-title":"Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin","volume":"555","author":"Zhou","year":"2003","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib87","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2170\/jjphysiol.33.677","article-title":"Anti-botulismic effect of toosendanin and its facilitatory action on miniature end-plate potentials","volume":"33","author":"Shih","year":"1983","journal-title":"Jpn J. Physiol."},{"key":"10.1016\/j.biopha.2023.115541_bib88","first-page":"259","article-title":"Electrophysiological analysis on the presynaptic blocking effects of toosendanin on neuromuscular transmission","volume":"33","author":"Shi","year":"1981","journal-title":"Acta Physiol. Sin."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115541_bib89","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(99)02129-0","article-title":"Effect of Toosendanin on acetylcholine level of rat brain, a microdialysis study","volume":"850","author":"Shi","year":"1999","journal-title":"Brain Res."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2023.115541_bib90","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0143-4160(98)90055-0","article-title":"Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release","volume":"24","author":"Catterall","year":"1998","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib91","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0006-8993(93)91184-T","article-title":"Action of toosendanin on the membrane current of mouse motor nerve terminals","volume":"631","author":"Xu","year":"1993","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib92","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0168-0102(01)00233-4","article-title":"Modulation of inward rectifier potassium channel by toosendanin, a presynaptic blocker","volume":"40","author":"Wang","year":"2001","journal-title":"Neurosci. Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-8993(96)01389-3","article-title":"Inhibition of Toosendanin on the delayed rectifier potassium current in neuroblastoma x glioma NG108-15 cells","volume":"751","author":"Hu","year":"1997","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib94","first-page":"147","article-title":"Effects of toosendanin on electric and mechanical properties of guinea pig papillary muscles","volume":"15","author":"Gao","year":"1994","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0306-4522(01)00051-3","article-title":"Inhibition of large-conductance Ca2+-activated K+ channels in hippocampal neurons by toosendanin","volume":"104","author":"Wang","year":"2001","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(01)01682-2","article-title":"Toosendanin-induced inhibition of small-conductance calcium-activated potassium channels in CA1 pyramidal neurons of rat hippocampus","volume":"303","author":"Wang","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2023.115541_bib97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0168-0102(01)00283-8","article-title":"Different effects of toosendanin on perineurially recorded Ca2+ currents in mouse and frog motor nerve terminals","volume":"41","author":"Ding","year":"2001","journal-title":"Neurosci. Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0306-4522(98)00057-8","article-title":"Diversity and properties of calcium channel types in NG108-15 hybrid cells","volume":"87","author":"Lukyanetz","year":"1998","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.biopha.2023.115541_bib99","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/aps.2009.35","article-title":"Toosendanin increases free-Ca2+ concentration in NG108-15 cells via L-type Ca2+ channels.","volume":"25","author":"Xu","year":"2004","journal-title":"Acta Pharm. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neures.2004.02.012","article-title":"Toosendanin, a triterpenoid derivative, increases Ca2+ current in NG108-15 cells via L-type channels","volume":"49","author":"Li","year":"2004","journal-title":"Neurosci. Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib101","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxicon.2004.09.010","article-title":"The long-term effect of toosendanin on current through nifedipine-sensitive Ca2+ channels in NG108-15 cells","volume":"45","author":"Li","year":"2005","journal-title":"Toxicon"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2023.115541_bib102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2004.08.027","article-title":"Toosendanin, a triterpenoid derivative, acts as a novel agonist of L-type Ca2+ channels in neonatal rat ventricular cells","volume":"501","author":"Li","year":"2004","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115541_bib103","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fphar.2019.01025","article-title":"Toosendanin from melia fructus suppresses influenza A virus infection by altering nuclear localization of viral polymerase PA protein","volume":"10","author":"Jin","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115541_bib104","article-title":"Screening of a small molecule compound library identifies toosendanin as an inhibitor against bunyavirus and SARS-CoV-2","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2023.115541_bib105","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/AAC.01780-10","article-title":"Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection","volume":"55","author":"Watanabe","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2023.115541_bib106","article-title":"Toosendanin suppresses African swine fever virus replication through upregulating interferon regulatory factor 1 in porcine alveolar macrophage cultures","volume":"13","author":"Liu","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib107","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-022-01077-2","article-title":"Toosendanin activates caspase-1 and induces maturation of IL-1\u03b2 to inhibit type 2 porcine reproductive and respiratory syndrome virus replication via an IFI16-dependent pathway","volume":"53","author":"Zhang","year":"2022","journal-title":"Vet. Res"},{"issue":"01","key":"10.1016\/j.biopha.2023.115541_bib108","first-page":"44","article-title":"Treatment of 130 cases of intestinal ascariasis with toosendanin tablets","author":"Xu","year":"1960","journal-title":"J. Nanjing Med. Univ. (Nat. Sci. )"},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib109","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s11418-020-01422-9","article-title":"Toosendanin relatives, trypanocidal principles from Meliae Cortex","volume":"74","author":"Mifundu","year":"2020","journal-title":"J. Nat. Med"},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1603\/ME12119","article-title":"Effects of the botanical insecticide, toosendanin, on blood digestion and egg production by female Aedes aegypti (Diptera: Culicidae): topical application and ingestion","volume":"50","author":"Ma","year":"2013","journal-title":"J. Med Entomol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib111","article-title":"Toosendanin inhibits adipogenesis by activating Wnt\/\u03b2-catenin signaling","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115541_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105909","article-title":"Toosendanin alleviates dextran sulfate sodium-induced colitis by inhibiting M1 macrophage polarization and regulating NLRP3 inflammasome and Nrf2\/HO-1 signaling","volume":"76","author":"Fan","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.115541_bib113","article-title":"Toosendanin restrains idiopathic pulmonary fibrosis by inhibiting ZEB1\/CTBP1 interaction","author":"Li","year":"2023","journal-title":"Curr. Mol. Med"},{"key":"10.1016\/j.biopha.2023.115541_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109745","article-title":"Toosendanin inhibits osteoclast formation and alleviate postmenopausal osteoporosis by regulating the p38 signaling pathway","volume":"116","author":"Tan","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115541_bib115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/bmc.2779","article-title":"Determination of toosendanin in rat plasma by ultra-performance liquid chromatography-electrospray ionization-mass spectrometry and its application in a pharmacokinetic study","volume":"27","author":"Wang","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"10","key":"10.1016\/j.biopha.2023.115541_bib116","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.3390\/molecules181012144","article-title":"Metabolite analysis of toosendanin by an ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry technique","volume":"18","author":"Wu","year":"2013","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.biopha.2023.115541_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4982","article-title":"Determination of toosendanin and trans-anethole in Fructus Meliae Toosendan and Fructus Foeniculi by HPLC-MS\/MS and GC-MS\/MS in rat plasma and their potential herb-herb interactions","volume":"34","author":"Yu","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.biopha.2023.115541_bib118","first-page":"469","article-title":"We must be careful of using toosendanin as an ascarifuge","volume":"11","author":"Hu","year":"1991","journal-title":"Zhonguo Yi Yuan Yao Xue Za Zhi"},{"issue":"07","key":"10.1016\/j.biopha.2023.115541_bib119","first-page":"29","article-title":"Pharmacological and toxicological study of toosendanin","volume":"13","author":"Li","year":"1982","journal-title":"J. ]. Chin. Herb. Med."},{"key":"10.1016\/j.biopha.2023.115541_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152867","article-title":"Identification of serum microRNAs as potential toxicological biomarkers for toosendanin-induced liver injury in mice","volume":"58","author":"Yang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.115541_bib121","doi-asserted-by":"crossref","first-page":"34225","DOI":"10.1038\/srep34225","article-title":"Integrated analysis of microRNA and mRNA expression profiles highlights the complex and dynamic behavior of toosendanin-induced liver injury in mice","volume":"6","author":"Lu","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115541_bib122","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acs.chemrestox.8b00350","article-title":"Integrated proteomics, biological functional assessments, and metabolomics reveal toosendanin-induced hepatic energy metabolic disorders","volume":"32","author":"Yan","year":"2019","journal-title":"Chem. Res Toxicol."},{"key":"10.1016\/j.biopha.2023.115541_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2021.109171","article-title":"Toosendanin triggered hepatotoxicity in zebrafish via inflammation, autophagy, and apoptosis pathways","volume":"250","author":"Sun","year":"2021","journal-title":"Comp. Biochem Physiol. C. Toxicol. Pharm."},{"issue":"01","key":"10.1016\/j.biopha.2023.115541_bib124","first-page":"94","article-title":"Effects of toosendanin on the toxicity of early pregnancy mice and its effect on Th1 cytokine content [J]","volume":"9","author":"Zhang","year":"2011","journal-title":"Chin. Vet. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tox.2008.04.005","article-title":"Roles of reactive oxygen species and MAP kinases in the primary rat hepatocytes death induced by toosendanin","volume":"249","author":"Zhang","year":"2008","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.biopha.2023.115541_bib126","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/tx5002145","article-title":"Identification of amino acid and glutathione N-conjugates of toosendanin: bioactivation of the furan ring mediated by CYP3A4","volume":"27","author":"Yu","year":"2014","journal-title":"Chem. Res Toxicol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115541_bib127","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/ph15121509","article-title":"Toosendanin induces hepatocyte damage by inhibiting autophagic flux via TFEB-mediated lysosomal dysfunction","volume":"15","author":"Luo","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2023.115541_bib128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.toxlet.2023.02.006","article-title":"Toosendanin induced hepatotoxicity via triggering PERK-eIF2\u03b1-ATF4 mediated ferroptosis","volume":"377","author":"Liang","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2023.115541_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112257","article-title":"Hepatotoxic evaluation of toosendanin via biomarker quantification and pathway mapping of large-scale chemical proteomics","volume":"153","author":"Zhuo","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115541_bib130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jgr.2021.03.001","article-title":"Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects","volume":"45","author":"Wan","year":"2021","journal-title":"J. Ginseng Res"},{"key":"10.1016\/j.biopha.2023.115541_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720474","article-title":"Emerging significance of ginsenosides as potentially reversal agents of chemoresistance in cancer therapy","volume":"12","author":"Xu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115541_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113207","article-title":"New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease","volume":"152","author":"Wu","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2023.115541_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106002","article-title":"Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases","volume":"175","author":"Wan","year":"2022","journal-title":"Pharm. Res."},{"issue":"16","key":"10.1016\/j.biopha.2023.115541_bib134","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.3390\/molecules24162930","article-title":"Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects","volume":"24","author":"Kotha","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115541_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175695","article-title":"Therapeutic potential of puerarin against cerebral diseases: from bench to bedside","volume":"953","author":"Liu","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115541_bib136","article-title":"Novel wine in an old bottle: preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases","author":"Tingting","year":"2023","journal-title":"J. Pharm. Anal."},{"issue":"15","key":"10.1016\/j.biopha.2023.115541_bib137","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.3390\/ijms20153642","article-title":"Surface-functionalized nanoparticles as efficient tools in targeted therapy of pregnancy complications","volume":"20","author":"Zhang","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115541_bib138","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41401-018-0024-8","article-title":"Quercetin attenuates toosendanin-induced hepatotoxicity through inducing the Nrf2\/GCL\/GSH antioxidant signaling pathway","volume":"40","author":"Jin","year":"2019","journal-title":"Acta Pharm. Sin."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:12:19Z","timestamp":1776460339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":138,"alternative-id":["S0753332223013392"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115541","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115541"}}